跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈

Elsevier
通过我们出版

Simplify regulatory searches with PharmaPendium AI

PharmaPendium AI is a natural language AI search tool on comprehensive regulatory data from the FDA and EMA. Rapid, in-depth responses surface regulatory precedents, helping regulatory affairs and R&D professionals reduce the risk of missing essential information. Optimize regulatory strategies with PharmaPendium AI.

Request a demo of PharmaPendium AI

Businessman and doctor looking at digital tablet in hospital corridor

Get critical regulatory insights quickly

A man with glasses smiling brightly.

Help users make informed drug pipeline and program decisions with PharmaPendium AI. Extract critical regulatory insights by leveraging natural language processing and machine learning. With this new tool, regulatory affairs, drug development and clinical research professionals can:

  • Pose questions in natural language.

  • Get responses from 5 million pages of verified FDA and EMA documents updated weekly.

  • Link to cited research information.

  • Ask follow-up questions.

  • Export sessions to easily maintain records.

Go further, faster with PharmaPendium AI.

Save time with intuitive searching

Screenshot of translated question in Pharmapendium

Ask questions in your own words to find regulatory precedents faster. Use follow-up questions to dig deeper.

Better support global teams with natural language search in multiple languages, including:

  • English

  • Chinese

  • French

  • German

  • Japanese

  • Korean

  • Spanish

Your searches are private. Developed using Elsevier’s Responsible AI Principles and Privacy Principles, PharmaPendium AI does not store information in the LLM or use it for training purposes.

Search trusted regulatory data with AI

Scientist using digital tech for data analysis, lab study and biotech test

PharmaPendium AI provides a summary based on the top 15 relevant documents from FDA and EMA regulatory content. Move forward with responses based on:

  • FDA approval packages since 1938

  • EMA approval documents since 1995

  • FDA Advisory Committee documents since 1983

  • Meyler’s Side Effects of Drugs 16th edition

Improve regulatory planning with highly relevant responses

Screenshot showing answers from regulatory documents in Pharmapendium

PharmaPendium AI helps regulatory affairs professionals and preclinical and clinical researchers anticipate risks and reduce regulatory cycling. Strengthen regulatory planning and submissions with responses:

  • Based on authoritative regulatory terminology

  • Verifiable via links to the original regulatory documents

  • Saved in your history for future reference

  • Delivered in flexible formats, including:

    • Table

    • Free text

    • Bullet points

    • CSV

What users say

PharmaPendium AI users are impressed with how it saves them time and help them make informed decisions.

“Quick access to regulatory precedents which can help me design better (nonclinical) strategies.” — Head of Nonclinical Toxicology and DMPK, Midsize Pharma

“Save time, speed up the processes, decrease the possibility of the human errors.” — Medical Alliances Operations Leader, Large Pharma

“Reduce timework, greater knowledge and helps for decisions and regulatory strategies.” — Regulatory Affairs Officer, Midsize Pharma

Quickly surface regulatory precedents with PharmaPendium AI